Other
Craig Rush
Total Trials
6
Recruiting
0
Active
0
Completed
6
Success Rate
100.0%+13% vs avg
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
Failure Rate
0.0%
0 terminated/withdrawn out of 6 trials
Success Rate
100.0%
+13.5% vs industry average
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
50%
3 of 6 completed trials have results
Key Signals
3 with results
Enrollment Performance
Analytics
Phase 1
3(50.0%)
Early Phase 1
2(33.3%)
N/A
1(16.7%)
6Total
Phase 1(3)
Early Phase 1(2)
N/A(1)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (6)
Showing 6 of 6 trials
NCT03575403Phase 1Completed
Behavioral Effects of Drugs: Inpatient (36) (Alcohol, Duloxetine, and Methylphenidate)
Role: lead
NCT04178993Phase 1Completed
Behavioral Effects of Drugs (Inpatient): 40 [Methamphetamine, Methylphenidate, Duloxetine]
Role: lead
NCT03438539Not ApplicableCompleted
Brief Online Interventions for Alcohol Use
Role: lead
NCT03519022Early Phase 1Completed
Behavioral Effects of Drugs: Inpatient (35)
Role: lead
NCT01739192Early Phase 1Completed
A Novel Anti-Obesity Drug Combination as a Pharmacotherapy for Cocaine Dependence
Role: lead
NCT00276874Phase 1Completed
Aripiprazole to Reduce Cocaine Relapse
Role: lead
All 6 trials loaded